What are the indications of COZING-OX01 4 liter portable oxygen concentrator?
- Asthma, bronchitis or emphysema.
- Chronic obstructive pulmonary disease (COPD)
- COVID-19. Cystic fibrosis
- Note: This is a supplementary medical equipment and is not intended for serious disease or those who stay alive solely on medical oxygen.
What's the technical parameter of the COZING-OX01 4 liter portable oxygen concentrator ?
|
Name |
Portable oxygen concentrator for home and Car Travel trip |
|
Voltage/Frequency |
220V±22V, 50Hz±Hz, 110V, 60Hz |
|
Power |
110W |
|
G.W |
6.5kg |
|
Oxygen flow rate |
1-5L/Min can be adjusted |
|
Oxygen concent |
>94% (under 1L oxygen flow rate) |
|
Noise |
≤45dB |
|
Dimension |
358mm(L)*321mm(W)*231mm(H) |
|
Oxygen generat method |
PSA |
|
Storage conditions |
Temperature-40°C-55°C, humidity<80% |
|
Oxygen density |
> 90% |
|
Atmospheric pressure |
50kPa-106kPa |
|
Oxygen purity |
Range from 30%-90% |
What are the advantages of COZING-OX01 4 liter portable oxygen concentrator?
1.Adopt the High quality alloy separation valve, to reduce the machine noise , operation stability and long use life.
2.High concentration, Oxygen output stability,Working is quiet, Remote control
3.The mute technology scientific design, and the noise low is 45db.
4. Big flow,high concentration,the concentration reach 90% , flow setting can be adjusted range from 1L to 5L.
5.Transparent monitoring system Large screen, data clear.
6.Intelligent and Compact.
How doesCOZING-OX01 4 liter portable oxygen concentrator for work?
Since portable oxygen concentrator for home are lighter and more compact than stationary ones, moving around and engaging in activities is made easier. Rechargeable lithium-ion batteries power the majority of portable oxygen concentrators.How air is turned into oxygen:
We begin with the most readily available resource: ambient air. This seemingly innocuous blend of gasses provides a vital part. While air contains roughly 78% nitrogen, our bodies crave and thrive on the 21% oxygen present.
The trick lies in separating these two components, and that's where the intricate dance of technology begins. First, it takes air from the room and proceeds by compressing oxygen. It then takes out nitrogen from the air. Once that is done, it adjusts the way the air is delivered and ends the process by air purification.
On a side note, the primary advantage of portable oxygen concentrator for home is their ability to facilitate better breathing. They could not totally alleviate dyspnea and are not a long term remedy for your ailment, but it does increase energy and improve sleep quality.
COZING-OX01 4 liter portable oxygen concentrator Display:
4 liter portable oxygen concentrator Clinical study:
BACKGROUND:The pulsed-dose oxygen-conserving device (PDOCD) is widely accepted as an efficient means to minimize the cost and inconvenience of portable oxygen therapy. While extensively used by patients during waking hours and mobility, few studies have investigated its effectiveness during sleep. This study aimed to compare heart rate and oxygen saturation (SpO2) during sleep between patients using a pulsed-dose oxygen-conserving device and those using continuous-flow oxygen.
METHODS:We examined 10 home-oxygen patients using various continuous-flow oxygen systems and prescriptions. Baseline asleep and awake SpO2 and heart rate were recorded while patients used their existing home-oxygen setups (liquid oxygen or oxygen concentrator with nasal cannula) and continuous-flow oxygen prescriptions. Subsequently, patients switched to a nasal cannula connected to a PDOCD, which was adjusted to match the awake SpO2 baseline of continuous-flow. This setting was maintained during sleep. Mean SpO2 and heart rate values, along with hours of sleep, were calculated using the oximeter software. Paired Student's t-test was employed to compare SpO2 and heart rate values.
RESULTS:A statistically significant but clinically minor difference in SpO2 was observed between continuous-flow oxygen and PDOCD use (95.7% vs. 93.2%, p = 0.043). No significant difference in heart rate was found (77.3 beats/min vs. 77.9 beats/min, p = 0.70). The sample size was sufficient to detect a heart rate difference of 5 beats/min with 80% power. For patients whose PDOCD triggering sensitivity was set to sensitive, a statistically significant but clinically minor difference in SpO2 was noted (95.6% continuous-flow vs. 93.2% PDOCD, p = 0.044). Other comparisons showed no differences, though sample sizes were too small for definitive conclusions. One patient experienced an 11% drop in SpO2 with the PDOCD due to insufficient triggering sensitivity.
CONCLUSIONS: The studied PDOCD model effectively delivered comparable oxygen therapy to continuous-flow oxygen in 9 out of 10 patients. Setting the PDOCD to the resting daytime SpO2 on continuous-flow ensures adequate oxygenation during sleep. This specific PDOCD model maintains adequate SpO2 during sleep for selected patients. However, variations in design, triggering sensitivity, and oxygen-pulse volume mean these results cannot be generalized to all patients or PDOCDs. Further research is needed to evaluate the broader performance of PDOCDs in larger populations and those with sleep-disordered breathing.
FAQ
